#ALERT: Health officials have warned "do not buy this product, do not use this product" after six Victorians developed liver damage from using an unapproved peptide, Retatrutide. The experimental peptide, which officials say "may not be what users think it is", is being clinically trialled for obesity and diabetes management by pharmaceutical company Eli Lilly, but is not approved by the Therapeutic Goods Administration or any other international regulatory agencies. #9News